Search

everythinglearnresearchcommunity

for

Search:↓

More men are getting cosmetic procedures, mainly for aging, hair loss, and to keep masculine features, with growing interest in both surgical and noninvasive treatments.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Skin health and diseases are closely linked to metabolic processes.

Finasteride, often used for hair loss, can potentially cause cataracts.

Dermoscopy helps diagnose unusual skin lesions like osteonevus of Nanta and can prevent misdiagnosis of serious conditions.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

The document says that there are treatments for hair and nail diseases.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Ultrasound boosts finasteride's hair growth effects in mice.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Platelet-Rich Plasma (PRP) treatment can significantly increase hair count and thickness in people with Androgenetic Alopecia (AGA) with minimal side effects.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Silencing SFRP1 alone promotes hair growth, but adding DKK1 does not help.

People with androgenetic alopecia often experience more anxiety, depression, and lower self-esteem.

Combining different drugs can improve hair loss treatment.

Major depression disorder increases the risk of alopecia areata, and vice versa.

Effective PCOS treatments require targeting specific signaling pathways.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Follicular unit grafting is a procedure used to treat hair loss, where small hair grafts are placed into the scalp, with future treatments likely to involve smaller incisions and cell-based therapies.

Dutasteride improved hair density and thickness in men not helped by finasteride, with minimal side effects.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.